Skip to Content

IDEXX Laboratories Inc

IDXX: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$824.00SbppltQhkrmhtzj

Idexx's Upcoming New InVue Platform Launch Should Support Growth Into the Long Term

Business Strategy and Outlook

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership continues to grow, offering a secular tailwind since the late 1980s. Moreover, pet owners have demonstrated greater willingness to spend more on their animals, having more than tripled spending on pet products and services since 1994.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of IDXX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center